首页 > 最新文献

Wiley最新文献

英文 中文
IF:
Differences in heroin overdose risk associated with the unregulated drug market: Insights from a supervised injecting facility in Melbourne, Australia. 与无管制毒品市场相关的海洛因过量风险差异:澳大利亚墨尔本一家受监管注射机构的观点。
IF 5.2 1区 医学 Q1 PSYCHIATRY Pub Date : 2025-02-01 Epub Date: 2024-11-08 DOI: 10.1111/add.16706
Nathan C Stam, John Furler, Sarah Hiley, Jennifer L Schumann

Aims: To determine the contribution that variation in the unregulated drug market has on the risk of heroin overdose across individuals with different levels of personal overdose risk.

Design: A retrospective cohort study of heroin injecting episodes and overdose cases were examined over a 12-month period between 30 June 2022 and 30 June 2023.

Setting: The Medically Supervised Injecting Room in Melbourne, Australia.

Cases: 1474 witnessed heroin overdose cases were examined amongst a cohort of 337 individuals who were predominantly male (n = 276, 81.7%) with a median age of 43.5 years (interquartile range 37.25-49.00 years, range 20-75 years).

Measurements: The daily overdose rate was used to differentiate High and Low daily overdose risk categories. The number of overdose events that an individual experienced during the study period was used to differentiate people into Standard, Moderate and High personal overdose risk categories. Each overdose case was differentiated by the personal overdose risk of the individual who experienced the overdose, as well as the overdose risk of the day that overdose occurred. A stratified overdose risk profile was then derived across the nine different daily overdose risk and personal overdose risk categories.

Findings: The rate of overdose approximately doubled on High overdose risk days compared with Standard overdose risk days, increasing by a factor of 2.11, 2.41 and 2.03 times for individuals in the Standard, Moderate and High personal overdose risk groups. Conversely, the rate of overdose was also substantially reduced on Low overdose risk days to a factor of 0.17, 0.28 and 0.20, respectively.

Conclusion: Among heroin users in Melbourne, Australia, there is an approximately 10-times difference in the risk of overdose on some days compared with others, which appears to be attributable to the effects of the unregulated drug market and not the effects of variation in personal overdose risk of individuals.

目的:确定无管制毒品市场的变化对不同个人用药过量风险水平的海洛因用药过量风险的影响:设计:在 2022 年 6 月 30 日至 2023 年 6 月 30 日的 12 个月期间,对海洛因注射事件和用药过量病例进行回顾性队列研究:环境:澳大利亚墨尔本的医疗监督注射室:在 337 名主要为男性(n = 276,81.7%)、年龄中位数为 43.5 岁(四分位数区间为 37.25-49.00 岁,范围为 20-75 岁)的人群中,对 1474 例目击海洛因过量病例进行了研究:每日用药过量率用于区分每日用药过量高风险和低风险类别。个人在研究期间经历的用药过量事件数量用于将个人用药过量风险分为标准、中度和高度类别。每个用药过量病例都根据用药过量者的个人用药过量风险以及用药过量发生当天的用药过量风险进行区分。然后根据九种不同的每日用药过量风险和个人用药过量风险类别得出分层用药过量风险概况:与标准用药过量风险日相比,用药过量高风险日的用药过量率大约翻了一番,标准、中度和高度个人用药过量风险组的用药过量率分别增加了 2.11 倍、2.41 倍和 2.03 倍。相反,用药过量低风险日的用药过量率也大幅降低,分别为 0.17、0.28 和 0.20 倍:结论:在澳大利亚墨尔本的海洛因吸食者中,某些日子的用药过量风险比其他日子高出约 10 倍,这似乎是由于不受管制的毒品市场造成的,而不是个人用药过量风险差异造成的。
{"title":"Differences in heroin overdose risk associated with the unregulated drug market: Insights from a supervised injecting facility in Melbourne, Australia.","authors":"Nathan C Stam, John Furler, Sarah Hiley, Jennifer L Schumann","doi":"10.1111/add.16706","DOIUrl":"10.1111/add.16706","url":null,"abstract":"<p><strong>Aims: </strong>To determine the contribution that variation in the unregulated drug market has on the risk of heroin overdose across individuals with different levels of personal overdose risk.</p><p><strong>Design: </strong>A retrospective cohort study of heroin injecting episodes and overdose cases were examined over a 12-month period between 30 June 2022 and 30 June 2023.</p><p><strong>Setting: </strong>The Medically Supervised Injecting Room in Melbourne, Australia.</p><p><strong>Cases: </strong>1474 witnessed heroin overdose cases were examined amongst a cohort of 337 individuals who were predominantly male (n = 276, 81.7%) with a median age of 43.5 years (interquartile range 37.25-49.00 years, range 20-75 years).</p><p><strong>Measurements: </strong>The daily overdose rate was used to differentiate High and Low daily overdose risk categories. The number of overdose events that an individual experienced during the study period was used to differentiate people into Standard, Moderate and High personal overdose risk categories. Each overdose case was differentiated by the personal overdose risk of the individual who experienced the overdose, as well as the overdose risk of the day that overdose occurred. A stratified overdose risk profile was then derived across the nine different daily overdose risk and personal overdose risk categories.</p><p><strong>Findings: </strong>The rate of overdose approximately doubled on High overdose risk days compared with Standard overdose risk days, increasing by a factor of 2.11, 2.41 and 2.03 times for individuals in the Standard, Moderate and High personal overdose risk groups. Conversely, the rate of overdose was also substantially reduced on Low overdose risk days to a factor of 0.17, 0.28 and 0.20, respectively.</p><p><strong>Conclusion: </strong>Among heroin users in Melbourne, Australia, there is an approximately 10-times difference in the risk of overdose on some days compared with others, which appears to be attributable to the effects of the unregulated drug market and not the effects of variation in personal overdose risk of individuals.</p>","PeriodicalId":109,"journal":{"name":"Addiction","volume":" ","pages":"285-292"},"PeriodicalIF":5.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707310/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142602462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Appropriate sampling to aid on-farm assessments of the haplotype composition of Zymoseptoria tritici populations. 进行适当的取样,以帮助在农场评估三尖杉蝽种群的单倍型组成。
IF 3.8 1区 农林科学 Q1 AGRONOMY Pub Date : 2025-02-01 Epub Date: 2024-10-11 DOI: 10.1002/ps.8454
Catherine Harrison, Neil Boonham, Roy Macarthur, Michael David Parr, Femke van den Berg

Background: Zymoseptoria tritici causes Septoria tritici blotch (STB), which is the biggest threat to wheat in the UK. Azole fungicides have been used since the 1980s to control STB, but resistance to these chemicals is now widespread. The main resistance mechanism is based on the accumulation of CYP51 mutations, with 33 mutations reported. Hence, farmers need an accurate estimate of the haplotype composition of Z. tritici populations to develop effective fungicide treatments and resistance management.

Results: Isolates from Z. tritici lesions were collected from three fields across three commercial farms using two sampling approaches. Analysis of the isolate sequences revealed that the number of distinct haplotypes and the haplotype composition of the most dominant haplotypes varied only between and not within farms. Conventional W-shaped and point sampling both found the same percentage of distinct haplotypes and frequencies of the six most dominant haplotypes.

Conclusion: The results from this survey suggest that farm-resistance-management strategies should be based on farm-specific rather than national data, and that sampling within a single field is sufficient. W-shaped sampling is often recommended in sampling approaches, but this survey finds no evidence of this approach being more appropriate for detecting a greater percentage of distinct haplotypes which may aid the discovery of potential new resistance threats. © 2024 Fera Science Ltd. Pest Management Science published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.

背景:三尖孢(Zymoseptoria tritici)会导致三尖孢(Septoria tritici)斑点病(STB),这是英国小麦面临的最大威胁。自 20 世纪 80 年代以来,唑类杀菌剂一直被用于控制 STB,但现在对这些化学品的抗性已十分普遍。主要的抗性机理是基于 CYP51 突变的积累,据报道有 33 种突变。因此,农民需要准确估计三尖杉属植物种群的单倍型组成,以制定有效的杀真菌剂处理和抗性管理方法:结果:采用两种取样方法,从三个商业农场的三块田地中采集了三尖杉病害分离株。对分离物序列的分析表明,不同单倍型的数量和最主要单倍型的单倍型组成只在农场之间有差异,而在农场内部没有差异。传统的 W 型采样和点式采样都发现了相同比例的独特单倍型和六个最主要单倍型的频率:本次调查的结果表明,农场抗性管理策略应基于特定农场而非全国数据,在单块田地内取样即可。取样方法中通常推荐 W 型取样,但本调查没有发现证据表明这种方法更适合检测更大比例的独特单倍型,这可能有助于发现潜在的新抗性威胁。© 2024 Fera Science Ltd.害虫管理科学》由 John Wiley & Sons Ltd 代表化学工业协会出版。
{"title":"Appropriate sampling to aid on-farm assessments of the haplotype composition of Zymoseptoria tritici populations.","authors":"Catherine Harrison, Neil Boonham, Roy Macarthur, Michael David Parr, Femke van den Berg","doi":"10.1002/ps.8454","DOIUrl":"10.1002/ps.8454","url":null,"abstract":"<p><strong>Background: </strong>Zymoseptoria tritici causes Septoria tritici blotch (STB), which is the biggest threat to wheat in the UK. Azole fungicides have been used since the 1980s to control STB, but resistance to these chemicals is now widespread. The main resistance mechanism is based on the accumulation of CYP51 mutations, with 33 mutations reported. Hence, farmers need an accurate estimate of the haplotype composition of Z. tritici populations to develop effective fungicide treatments and resistance management.</p><p><strong>Results: </strong>Isolates from Z. tritici lesions were collected from three fields across three commercial farms using two sampling approaches. Analysis of the isolate sequences revealed that the number of distinct haplotypes and the haplotype composition of the most dominant haplotypes varied only between and not within farms. Conventional W-shaped and point sampling both found the same percentage of distinct haplotypes and frequencies of the six most dominant haplotypes.</p><p><strong>Conclusion: </strong>The results from this survey suggest that farm-resistance-management strategies should be based on farm-specific rather than national data, and that sampling within a single field is sufficient. W-shaped sampling is often recommended in sampling approaches, but this survey finds no evidence of this approach being more appropriate for detecting a greater percentage of distinct haplotypes which may aid the discovery of potential new resistance threats. © 2024 Fera Science Ltd. Pest Management Science published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.</p>","PeriodicalId":218,"journal":{"name":"Pest Management Science","volume":" ","pages":"599-606"},"PeriodicalIF":3.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11716361/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142398867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effects of duration of any breastfeeding on body mass index in Australian children: Exploration of health, economic and equity impacts. 母乳喂养持续时间对澳大利亚儿童体重指数的影响:探讨对健康、经济和公平的影响。
IF 2.7 3区 医学 Q1 PEDIATRICS Pub Date : 2025-02-01 Epub Date: 2024-08-29 DOI: 10.1111/ijpo.13167
Joseph Carrello, Vicki Brown, Anagha Killedar, Alison Hayes

Background: Breastfeeding is a protective measure against childhood overweight and obesity. However, many children are not breastfed the recommended duration, with those from disadvantaged backgrounds more likely to cease breastfeeding early.

Objectives: Investigate the association between duration of any breastfeeding and body mass index (BMI) and estimate the health, economic and equity impacts of increasing breastfeeding duration to at least 6 months.

Methods: We modelled the association between any breastfeeding duration and BMI at age 6/7 years, using a nationally representative cohort of 3935 Australian children (survey weighted to 221 103 children). We then used a simulation model to predict the impact of increasing breastfeeding duration to at least 6 months in all children on prevalence of overweight (including obesity) and associated healthcare costs to age 16/17 years.

Results: Achieving breastfeeding duration of at least 6 months could prevent 2933 cases of overweight at age 16/17 years, translating to healthcare cost-savings of AUD $4.29 million. Although most cases (68%) would come from low socio-economic backgrounds this would make only a minor difference in reducing inequalities.

Conclusion: Efforts to support increased breastfeeding duration could result in reduced prevalence of overweight and obesity and save healthcare costs, however, additional action would be required to improve equity.

背景:母乳喂养是防止儿童超重和肥胖的一种保护措施。然而,许多儿童的母乳喂养时间并没有达到建议的期限,来自贫困家庭的儿童更有可能过早停止母乳喂养:调查母乳喂养持续时间与体重指数(BMI)之间的关系,并估算将母乳喂养持续时间延长至至少 6 个月对健康、经济和公平的影响:我们利用具有全国代表性的 3935 名澳大利亚儿童队列(调查加权为 221 103 名儿童),模拟了任何母乳喂养持续时间与 6/7 岁体重指数之间的关系。然后,我们使用模拟模型预测了将所有儿童的母乳喂养时间延长至至少 6 个月对超重(包括肥胖)发生率和 16-17 岁相关医疗成本的影响:结果:母乳喂养至少持续 6 个月可预防 2933 例 16/17 岁儿童超重,节省医疗成本 429 万澳元。尽管大多数病例(68%)来自社会经济地位较低的家庭,但这对减少不平等现象的影响微乎其微:支持延长母乳喂养时间的努力可降低超重和肥胖的发生率,并节约医疗成本,但还需要采取额外的行动来提高公平性。
{"title":"The effects of duration of any breastfeeding on body mass index in Australian children: Exploration of health, economic and equity impacts.","authors":"Joseph Carrello, Vicki Brown, Anagha Killedar, Alison Hayes","doi":"10.1111/ijpo.13167","DOIUrl":"10.1111/ijpo.13167","url":null,"abstract":"<p><strong>Background: </strong>Breastfeeding is a protective measure against childhood overweight and obesity. However, many children are not breastfed the recommended duration, with those from disadvantaged backgrounds more likely to cease breastfeeding early.</p><p><strong>Objectives: </strong>Investigate the association between duration of any breastfeeding and body mass index (BMI) and estimate the health, economic and equity impacts of increasing breastfeeding duration to at least 6 months.</p><p><strong>Methods: </strong>We modelled the association between any breastfeeding duration and BMI at age 6/7 years, using a nationally representative cohort of 3935 Australian children (survey weighted to 221 103 children). We then used a simulation model to predict the impact of increasing breastfeeding duration to at least 6 months in all children on prevalence of overweight (including obesity) and associated healthcare costs to age 16/17 years.</p><p><strong>Results: </strong>Achieving breastfeeding duration of at least 6 months could prevent 2933 cases of overweight at age 16/17 years, translating to healthcare cost-savings of AUD $4.29 million. Although most cases (68%) would come from low socio-economic backgrounds this would make only a minor difference in reducing inequalities.</p><p><strong>Conclusion: </strong>Efforts to support increased breastfeeding duration could result in reduced prevalence of overweight and obesity and save healthcare costs, however, additional action would be required to improve equity.</p>","PeriodicalId":217,"journal":{"name":"Pediatric Obesity","volume":" ","pages":"e13167"},"PeriodicalIF":2.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11710949/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142102716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The origin of great ape gestural forms. 巨猿手势的起源
IF 11 1区 生物学 Q1 BIOLOGY Pub Date : 2025-02-01 Epub Date: 2024-08-27 DOI: 10.1111/brv.13136
Kirsty E Graham, Federico Rossano, Richard T Moore

Two views claim to account for the origins of great ape gestural forms. On the Leipzig view, gestural forms are ontogenetically ritualised from action sequences between pairs of individuals. On the St Andrews view, gestures are the product of natural selection for shared gestural forms. The Leipzig view predicts within- and between-group differences between gestural forms that arise as a product of learning in ontogeny. The St Andrews view predicts universal gestural forms comprehensible within and between species that arise because gestural forms were a target of natural selection. We reject both accounts and propose an alternative "recruitment view" of the origins of great ape gestures. According to the recruitment view, great ape gestures recruit features of their existing behavioural repertoire for communicative purposes. Their gestures inherit their communicative functions from visual (and sometimes tactile) presentations of familiar and easily recognisable action schemas and states and parts of the body. To the extent that great ape species possess similar bodies, this predicts mutual comprehensibility within and between species - but without supposing that gestural forms were themselves targets of natural selection. Additionally, we locate great ape gestural communication within a pragmatic framework that is continuous with human communication, and make testable predications for adjudicating between the three alternative views. We propose that the recruitment view best explains existing data, and does so within a mechanistic framework that emphasises continuity between human and non-human great ape communication.

有两种观点可以解释巨猿手势的起源。莱比锡观点认为,手势是一对个体之间的动作序列在本体上形成的仪式。根据圣安德鲁斯的观点,手势是自然选择共享手势形式的产物。莱比锡观点认为,手势形式在群体内部和群体之间存在差异,这种差异是本体学习的产物。圣安德鲁斯的观点则认为,由于手势形式是自然选择的目标,因此在物种内部和物种之间出现了可以理解的普遍手势形式。我们反对这两种观点,并提出了巨猿手势起源的另一种 "招募观点"。根据这种观点,类人猿的手势是出于交流的目的,从它们现有的行为剧目中吸收了一些特征。它们的手势从视觉上(有时是触觉上)呈现熟悉和易于识别的动作模式、状态和身体部位,从而继承了它们的交流功能。只要类人猿物种拥有相似的身体,这就预示着它们在物种内部和物种之间是可以相互理解的--但这并不意味着手势形式本身就是自然选择的目标。此外,我们将类人猿的手势交流定位在一个与人类交流具有连续性的实用主义框架内,并提出了可检验的预言,以便在三种可选观点之间做出判断。我们提出,招募观点最能解释现有数据,而且是在强调人类与非人类巨猿交流连续性的机制框架内解释的。
{"title":"The origin of great ape gestural forms.","authors":"Kirsty E Graham, Federico Rossano, Richard T Moore","doi":"10.1111/brv.13136","DOIUrl":"10.1111/brv.13136","url":null,"abstract":"<p><p>Two views claim to account for the origins of great ape gestural forms. On the Leipzig view, gestural forms are ontogenetically ritualised from action sequences between pairs of individuals. On the St Andrews view, gestures are the product of natural selection for shared gestural forms. The Leipzig view predicts within- and between-group differences between gestural forms that arise as a product of learning in ontogeny. The St Andrews view predicts universal gestural forms comprehensible within and between species that arise because gestural forms were a target of natural selection. We reject both accounts and propose an alternative \"recruitment view\" of the origins of great ape gestures. According to the recruitment view, great ape gestures recruit features of their existing behavioural repertoire for communicative purposes. Their gestures inherit their communicative functions from visual (and sometimes tactile) presentations of familiar and easily recognisable action schemas and states and parts of the body. To the extent that great ape species possess similar bodies, this predicts mutual comprehensibility within and between species - but without supposing that gestural forms were themselves targets of natural selection. Additionally, we locate great ape gestural communication within a pragmatic framework that is continuous with human communication, and make testable predications for adjudicating between the three alternative views. We propose that the recruitment view best explains existing data, and does so within a mechanistic framework that emphasises continuity between human and non-human great ape communication.</p>","PeriodicalId":133,"journal":{"name":"Biological Reviews","volume":" ","pages":"190-204"},"PeriodicalIF":11.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11718593/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142078528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sharing the motherload: A review and development of the CO-Parent conceptual model for early childhood obesity prevention. 分担母亲的负担:儿童早期肥胖预防的 CO-Parent 概念模型回顾与发展。
IF 8 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-02-01 Epub Date: 2024-10-17 DOI: 10.1111/obr.13853
Konsita Kuswara, Vanessa A Shrewsbury, Jacqui A Macdonald, Alexandra Chung, Briony Hill

Fathers remain under-represented in early childhood obesity prevention research and interventions, despite growing evidence that paternal biopsychosocial factors and behaviors from pre- and post-conception can influence lifelong offspring health. Informed by a literature review of high-quality evidence, "CO-Parent" (childhood obesity-Parent) is a new conceptual model underpinned by couple interdependence theory and a socioecological framework. Literature was searched for the concepts parental AND weight-related behaviors AND child weight or weight-related behaviors, in databases including MEDLINE, PsycINFO, Global Health, Scopus, and SocINDEX. Prior evidence syntheses were prioritized as source data to inform model development. "CO-Parent" illustrates the interdependent and independent effects of maternal and paternal weight, weight-related behaviors, and well-being, across preconception, pregnancy, postpartum, and the early years on child weight-related behaviors and weight up to age five. The influences of public policy, social, environmental, economic, community, and other complex modifiable mediating factors are included in the model. The "CO-Parent" conceptual model paves the way for a paradigm shift by recognizing fathers as key figures in early childhood obesity prevention initiatives, encouraging them to "share the motherload." It highlights both the independent and interdependent roles fathers play in the epidemiology of obesity starting from preconception. CO-Parent also provides the foundations necessary to guide future theory and research to be more inclusive of fathers to further understanding of the independent and interdependent influences of parents in early childhood obesity prevention.

尽管越来越多的证据表明,父亲在孕前和孕后的生物心理社会因素和行为会影响后代的终生健康,但父亲在儿童早期肥胖预防研究和干预措施中的代表性仍然不足。根据对高质量证据的文献综述,"CO-父母"(儿童肥胖-父母)是一个新的概念模型,以夫妻相互依存理论和社会生态框架为基础。我们在 MEDLINE、PsycINFO、Global Health、Scopus 和 SocINDEX 等数据库中搜索了有关父母、体重相关行为、儿童体重或体重相关行为等概念的文献。之前的证据综述被优先作为源数据,为模型开发提供信息。"CO-Parent "说明了母亲和父亲的体重、体重相关行为和幸福感在孕前、孕期、产后和幼儿期对儿童体重相关行为和五岁前体重的相互依存和独立影响。该模型还包括公共政策、社会、环境、经济、社区和其他复杂的可调节中介因素的影响。父母共同责任 "概念模型承认父亲是儿童早期肥胖预防计划的关键人物,鼓励他们 "分担母亲的责任",从而为范式转变铺平了道路。它强调了父亲从孕前开始在肥胖流行病学中扮演的独立和相互依存的角色。父母共同承担》还为指导未来的理论和研究提供了必要的基础,使其更加包容父亲,从而进一步了解父母在儿童早期肥胖预防中的独立和相互依存的影响。
{"title":"Sharing the motherload: A review and development of the CO-Parent conceptual model for early childhood obesity prevention.","authors":"Konsita Kuswara, Vanessa A Shrewsbury, Jacqui A Macdonald, Alexandra Chung, Briony Hill","doi":"10.1111/obr.13853","DOIUrl":"10.1111/obr.13853","url":null,"abstract":"<p><p>Fathers remain under-represented in early childhood obesity prevention research and interventions, despite growing evidence that paternal biopsychosocial factors and behaviors from pre- and post-conception can influence lifelong offspring health. Informed by a literature review of high-quality evidence, \"CO-Parent\" (childhood obesity-Parent) is a new conceptual model underpinned by couple interdependence theory and a socioecological framework. Literature was searched for the concepts parental AND weight-related behaviors AND child weight or weight-related behaviors, in databases including MEDLINE, PsycINFO, Global Health, Scopus, and SocINDEX. Prior evidence syntheses were prioritized as source data to inform model development. \"CO-Parent\" illustrates the interdependent and independent effects of maternal and paternal weight, weight-related behaviors, and well-being, across preconception, pregnancy, postpartum, and the early years on child weight-related behaviors and weight up to age five. The influences of public policy, social, environmental, economic, community, and other complex modifiable mediating factors are included in the model. The \"CO-Parent\" conceptual model paves the way for a paradigm shift by recognizing fathers as key figures in early childhood obesity prevention initiatives, encouraging them to \"share the motherload.\" It highlights both the independent and interdependent roles fathers play in the epidemiology of obesity starting from preconception. CO-Parent also provides the foundations necessary to guide future theory and research to be more inclusive of fathers to further understanding of the independent and interdependent influences of parents in early childhood obesity prevention.</p>","PeriodicalId":216,"journal":{"name":"Obesity Reviews","volume":" ","pages":"e13853"},"PeriodicalIF":8.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11711075/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142454272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification and Characterization of Innate Immunity in Actinidia melanandra in Response to Pseudomonas syringae pv. actinidiae. 鉴定和描述黑色放线菌对 Pseudomonas syringae pv. actinidiae 的先天免疫反应。
IF 6 1区 生物学 Q1 PLANT SCIENCES Pub Date : 2025-02-01 Epub Date: 2024-10-13 DOI: 10.1111/pce.15189
Lauren M Hemara, Abhishek Chatterjee, Shin-Mei Yeh, Ronan K Y Chen, Elena Hilario, Liam Le Lievre, Ross N Crowhurst, Deborah Bohne, Saadiah Arshed, Haileigh R Patterson, Kelvina Barrett-Manako, Susan Thomson, Andrew C Allan, Cyril Brendolise, David Chagné, Matthew D Templeton, Jibran Tahir, Jay Jayaraman

Pseudomonas syringae pv. actinidiae biovar 3 (Psa3) has decimated kiwifruit orchards growing susceptible kiwifruit Actinidia chinensis varieties. Effector loss has occurred recently in Psa3 isolates from resistant kiwifruit germplasm, resulting in strains capable of partially overcoming resistance present in kiwiberry vines (Actinidia arguta, Actinidia polygama, and Actinidia melanandra). Diploid male A. melanandra recognises several effectors, sharing recognition of at least one avirulence effector (HopAW1a) with previously studied tetraploid kiwiberry vines. Sequencing and assembly of the A. melanandra genome enabled the characterisation of the transcriptomic response of this non-host to wild-type and genetic mutants of Psa3. A. melanandra appears to mount a classic effector-triggered immunity (ETI) response to wildtype Psa3 V-13, as expected. Surprisingly, the type III secretion (T3SS) system-lacking Psa3 V-13 ∆hrcC strain did not appear to trigger pattern-triggered immunity (PTI) despite lacking the ability to deliver immunity-suppressing effectors. Contrasting the A. melanandra responses to an effectorless Psa3 V-13 ∆33E strain and to Psa3 V-13 ∆hrcC suggested that PTI triggered by Psa3 V-13 was based on the recognition of the T3SS itself. The characterisation of both ETI and PTI branches of innate immunity responses within A. melanandra further enables breeding for durable resistance in future kiwifruit cultivars.

Pseudomonas syringae pv. actinidiae biovar 3(Psa3)已使种植易感猕猴桃 Actinidia chinensis 品种的猕猴桃果园遭受灭顶之灾。最近,从抗性猕猴桃种质中分离出的 Psa3 株系中出现了效应器缺失,从而产生了能够部分克服猕猴桃藤蔓(Actinidia arguta、Actinidia polygama 和 Actinidia melanandra)抗性的株系。二倍体雄性 A. melanandra 能识别多种效应物,与之前研究过的四倍体猕猴桃藤共同识别至少一种抗性效应物(HopAW1a)。通过对 A. melanandra 基因组的测序和组装,可以确定这种非宿主对 Psa3 野生型和遗传突变体的转录组反应的特征。正如预期的那样,A. melanandra似乎对野生型Psa3 V-13做出了典型的效应触发免疫(ETI)反应。令人惊讶的是,缺乏 III 型分泌(T3SS)系统的 Psa3 V-13 ∆hrcC 菌株尽管缺乏传递免疫抑制效应物的能力,但似乎并没有触发模式触发免疫(PTI)。对比黑腹角雉对无效应物的 Psa3 V-13 ∆33E 株系和 Psa3 V-13 ∆hrcC 株系的反应,发现 Psa3 V-13 触发的 PTI 是基于对 T3SS 本身的识别。对 A. melanandra 体内先天性免疫反应的 ETI 和 PTI 两个分支进行鉴定,有助于进一步培育未来猕猴桃栽培品种的持久抗性。
{"title":"Identification and Characterization of Innate Immunity in Actinidia melanandra in Response to Pseudomonas syringae pv. actinidiae.","authors":"Lauren M Hemara, Abhishek Chatterjee, Shin-Mei Yeh, Ronan K Y Chen, Elena Hilario, Liam Le Lievre, Ross N Crowhurst, Deborah Bohne, Saadiah Arshed, Haileigh R Patterson, Kelvina Barrett-Manako, Susan Thomson, Andrew C Allan, Cyril Brendolise, David Chagné, Matthew D Templeton, Jibran Tahir, Jay Jayaraman","doi":"10.1111/pce.15189","DOIUrl":"10.1111/pce.15189","url":null,"abstract":"<p><p>Pseudomonas syringae pv. actinidiae biovar 3 (Psa3) has decimated kiwifruit orchards growing susceptible kiwifruit Actinidia chinensis varieties. Effector loss has occurred recently in Psa3 isolates from resistant kiwifruit germplasm, resulting in strains capable of partially overcoming resistance present in kiwiberry vines (Actinidia arguta, Actinidia polygama, and Actinidia melanandra). Diploid male A. melanandra recognises several effectors, sharing recognition of at least one avirulence effector (HopAW1a) with previously studied tetraploid kiwiberry vines. Sequencing and assembly of the A. melanandra genome enabled the characterisation of the transcriptomic response of this non-host to wild-type and genetic mutants of Psa3. A. melanandra appears to mount a classic effector-triggered immunity (ETI) response to wildtype Psa3 V-13, as expected. Surprisingly, the type III secretion (T3SS) system-lacking Psa3 V-13 ∆hrcC strain did not appear to trigger pattern-triggered immunity (PTI) despite lacking the ability to deliver immunity-suppressing effectors. Contrasting the A. melanandra responses to an effectorless Psa3 V-13 ∆33E strain and to Psa3 V-13 ∆hrcC suggested that PTI triggered by Psa3 V-13 was based on the recognition of the T3SS itself. The characterisation of both ETI and PTI branches of innate immunity responses within A. melanandra further enables breeding for durable resistance in future kiwifruit cultivars.</p>","PeriodicalId":222,"journal":{"name":"Plant, Cell & Environment","volume":" ","pages":"1037-1050"},"PeriodicalIF":6.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11695773/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142454334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Early Intervention for Early Psychosis on Suicidal Behavior-A Meta-Analysis. 早期精神病早期干预对自杀行为的影响--Meta 分析。
IF 5.3 2区 医学 Q1 PSYCHIATRY Pub Date : 2025-02-01 Epub Date: 2024-11-27 DOI: 10.1111/acps.13773
Elkhan Tahmazov, Jordan Bosse, Benjamin Glemain, Patrice Nabbe, Morgane Guillou, Athéna Blachier, Michel Walter, Christophe Lemey

Introduction: Early-onset psychotic disorders include the prodromal phase and the first-episode psychosis (FEP). They constitute a high-risk period for suicidal behavior. Early intervention for psychosis (EIP) consists of intervening as early as possible. The effectiveness of early intervention on overall prognosis has been reported in numerous studies, and EIP services are emerging worldwide. Several authors report an improvement in suicidal behavior, but no study has looked at all the data.

Aims of the study: The aim of work is to study whether early intervention for psychosis has an impact on deaths by suicide and suicide attempts, and study which intervention methods have an impact on suicidal behavior.

Methodology: By respecting the PRISMA criteria, previously declared on PROSPERO, by exploring 5 medical databases (PubMed, Cochrane, PsycINFO, Scopus, Embase), from their creation dates, published until 20/02/2023, in English, we carried out a meta-analysis. The articles selected had to deal with the EIP and deaths by suicide or suicide attempts. Our primary outcome is the deaths by suicide and the secondary outcome the suicide attempt.

Results: The exhaustive search identified a total of 2310 references. Nine articles were included. Their intervention modalities were pharmacotherapy, psychotherapy, case-management, or related services, and psycho-social therapies. Our meta-analysis shows that early intervention for early-onset psychotic disorders is associated with a statistically significant reduction by a third in deaths by suicide (ORa = 0.66 (0.49-0.88), p = 0.005) and by a third in suicide attempts (ORa = 0.66 (0.50-0.86), p = 0.002), with non-significant heterogeneity. Sensitivity analyses excluding the study with statistical difficulties due to the absence of an event and studies with a high risk of bias point in the same direction, that is a statistically significant reduction and non-significant heterogeneity.

Conclusion: The literature shows that early intervention programs are associated with positive impact on deaths by suicide and suicide attempt. This is the first meta-analysis of early intervention in early psychotic disorders and its impact on suicidal risk. The deployment of EIP should be supported worldwide in order to intervene as early as possible and prevent the risk of suicide.

Trial registration: PROSPERO CRD42022366976.

简介早发精神病包括前驱期和首发精神病(FEP)。它们是自杀行为的高危期。精神病早期干预(EIP)包括尽早干预。许多研究都报道了早期干预对总体预后的有效性,而且 EIP 服务正在全球范围内兴起。一些作者报告称,自杀行为有所改善,但还没有研究对所有数据进行调查:工作目的:研究精神病早期干预是否会对自杀死亡和自杀未遂产生影响,并研究哪些干预方法会对自杀行为产生影响:通过遵守 PRISMA 标准(之前已在 PROSPERO 上声明),探索 5 个医学数据库(PubMed、Cochrane、PsycINFO、Scopus、Embase)中自创建之日起至 2023 年 2 月 20 日发表的英文文献,我们进行了一项荟萃分析。所选文章必须涉及 EIP 和自杀或自杀未遂死亡。我们的主要结果是自杀死亡,次要结果是自杀未遂:通过详尽搜索,共找到 2310 篇参考文献。九篇文章被纳入其中。其干预方式包括药物疗法、心理疗法、个案管理或相关服务以及社会心理疗法。我们的荟萃分析表明,对早发性精神病的早期干预可使自杀死亡人数减少三分之一(ORa = 0.66 (0.49-0.88),p = 0.005),自杀未遂人数减少三分之一(ORa = 0.66 (0.50-0.86),p = 0.002),异质性不显著。敏感性分析排除了因未发生事件而导致统计困难的研究和偏倚风险较高的研究,结果指向相同的方向,即在统计上显著降低,异质性不显著:文献显示,早期干预计划对自杀死亡和自杀未遂有积极影响。这是首次对早期精神障碍的早期干预及其对自杀风险的影响进行荟萃分析。为了尽早干预并预防自杀风险,EIP的部署应在全球范围内得到支持:试验注册:PREMCOCRD42022366976。
{"title":"Impact of Early Intervention for Early Psychosis on Suicidal Behavior-A Meta-Analysis.","authors":"Elkhan Tahmazov, Jordan Bosse, Benjamin Glemain, Patrice Nabbe, Morgane Guillou, Athéna Blachier, Michel Walter, Christophe Lemey","doi":"10.1111/acps.13773","DOIUrl":"10.1111/acps.13773","url":null,"abstract":"<p><strong>Introduction: </strong>Early-onset psychotic disorders include the prodromal phase and the first-episode psychosis (FEP). They constitute a high-risk period for suicidal behavior. Early intervention for psychosis (EIP) consists of intervening as early as possible. The effectiveness of early intervention on overall prognosis has been reported in numerous studies, and EIP services are emerging worldwide. Several authors report an improvement in suicidal behavior, but no study has looked at all the data.</p><p><strong>Aims of the study: </strong>The aim of work is to study whether early intervention for psychosis has an impact on deaths by suicide and suicide attempts, and study which intervention methods have an impact on suicidal behavior.</p><p><strong>Methodology: </strong>By respecting the PRISMA criteria, previously declared on PROSPERO, by exploring 5 medical databases (PubMed, Cochrane, PsycINFO, Scopus, Embase), from their creation dates, published until 20/02/2023, in English, we carried out a meta-analysis. The articles selected had to deal with the EIP and deaths by suicide or suicide attempts. Our primary outcome is the deaths by suicide and the secondary outcome the suicide attempt.</p><p><strong>Results: </strong>The exhaustive search identified a total of 2310 references. Nine articles were included. Their intervention modalities were pharmacotherapy, psychotherapy, case-management, or related services, and psycho-social therapies. Our meta-analysis shows that early intervention for early-onset psychotic disorders is associated with a statistically significant reduction by a third in deaths by suicide (ORa = 0.66 (0.49-0.88), p = 0.005) and by a third in suicide attempts (ORa = 0.66 (0.50-0.86), p = 0.002), with non-significant heterogeneity. Sensitivity analyses excluding the study with statistical difficulties due to the absence of an event and studies with a high risk of bias point in the same direction, that is a statistically significant reduction and non-significant heterogeneity.</p><p><strong>Conclusion: </strong>The literature shows that early intervention programs are associated with positive impact on deaths by suicide and suicide attempt. This is the first meta-analysis of early intervention in early psychotic disorders and its impact on suicidal risk. The deployment of EIP should be supported worldwide in order to intervene as early as possible and prevent the risk of suicide.</p><p><strong>Trial registration: </strong>PROSPERO CRD42022366976.</p>","PeriodicalId":108,"journal":{"name":"Acta Psychiatrica Scandinavica","volume":" ","pages":"127-141"},"PeriodicalIF":5.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11695091/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142724389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Benefits of combining SGLT2 inhibitors and pioglitazone on risk of MASH in type 2 diabetes-A real-world study. 联合使用 SGLT2 抑制剂和吡格列酮对 2 型糖尿病患者 MASH 风险的益处--一项真实世界研究。
IF 5.4 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-02-01 Epub Date: 2024-11-05 DOI: 10.1111/dom.16049
Chi-Ho Lee, David Tak-Wai Lui, Lung-Yi Mak, Carol Ho-Yi Fong, Kylie Sze-Wing Chan, Jimmy Ho-Cheung Mak, Chloe Yu-Yan Cheung, Wing-Sun Chow, Yu-Cho Woo, Man-Fung Yuen, Wai-Kay Seto, Karen Siu-Ling Lam

Aims: Both pioglitazone and glucagon-like peptide 1 receptor agonists (GLP1RA) alone improve metabolic dysfunction-associated steatohepatitis (MASH) in randomized clinical trials, whereas preclinical studies suggested MASH benefits with sodium glucose co-transporter 2 inhibitors (SGLT2i). In the real world, patients with type 2 diabetes often require multiple agents for glycaemic control. Here, we investigated the benefits of combining these agents on risks of MASH.

Materials and methods: Longitudinal changes in FibroScan-aspartate aminotransferase (FAST) score were measured in 888 patients with type 2 diabetes. Use of pioglitazone, GLP1RA and/or SGLT2i was defined as continuous prescriptions of ≥180 days prior to their last reassessment FibroScan. Multivariable logistic regression analysis was conducted to evaluate the associations between use of these agents and FAST score changes.

Results: Over a median follow-up of 3.9 years, the increasing number of these agents used was significantly associated with more reductions in FAST score (p for trend <0.01). Dual combination was independently associated with a higher likelihood of achieving low FAST score at reassessment than single use of any of these agents (odds ratio [OR] 2.84, p = 0.01). Among the different drug combinations, using SGLT2i and pioglitazone (median dose 15 mg daily) together, as compared to not using any of these three agents, was associated with a higher likelihood of both low FAST score at reassessment (OR 6.51, p = 0.008) and FAST score regression (OR 12.52, p = 0.009), after adjusting for changes in glycaemic control and body weight during the study.

Conclusions: Combining SGLT2i and pioglitazone is a potentially useful strategy to ameliorate 'at-risk' MASH in patients with type 2 diabetes.

目的:在随机临床试验中,单独使用吡格列酮和胰高血糖素样肽 1 受体激动剂(GLP1RA)均可改善代谢功能障碍相关性脂肪性肝炎(MASH),而临床前研究表明,使用钠葡萄糖协同转运体 2 抑制剂(SGLT2i)可改善代谢功能障碍相关性脂肪性肝炎。在现实世界中,2 型糖尿病患者往往需要多种药物来控制血糖。在此,我们研究了联合使用这些药物对 MASH 风险的益处:对 888 名 2 型糖尿病患者的纤维扫描-天门冬氨酸氨基转移酶(FAST)评分的纵向变化进行了测量。使用吡格列酮、GLP1RA 和/或 SGLT2i 的定义是在最后一次纤维扫描复查前连续处方≥180 天。我们进行了多变量逻辑回归分析,以评估使用这些药物与 FAST 评分变化之间的关联:结果:在中位 3.9 年的随访中,这些药物使用次数的增加与 FAST 评分的降低显著相关(p 为趋势结论):联合使用 SGLT2i 和吡格列酮可能是改善 2 型糖尿病患者 "高危 "MASH 的有效策略。
{"title":"Benefits of combining SGLT2 inhibitors and pioglitazone on risk of MASH in type 2 diabetes-A real-world study.","authors":"Chi-Ho Lee, David Tak-Wai Lui, Lung-Yi Mak, Carol Ho-Yi Fong, Kylie Sze-Wing Chan, Jimmy Ho-Cheung Mak, Chloe Yu-Yan Cheung, Wing-Sun Chow, Yu-Cho Woo, Man-Fung Yuen, Wai-Kay Seto, Karen Siu-Ling Lam","doi":"10.1111/dom.16049","DOIUrl":"10.1111/dom.16049","url":null,"abstract":"<p><strong>Aims: </strong>Both pioglitazone and glucagon-like peptide 1 receptor agonists (GLP1RA) alone improve metabolic dysfunction-associated steatohepatitis (MASH) in randomized clinical trials, whereas preclinical studies suggested MASH benefits with sodium glucose co-transporter 2 inhibitors (SGLT2i). In the real world, patients with type 2 diabetes often require multiple agents for glycaemic control. Here, we investigated the benefits of combining these agents on risks of MASH.</p><p><strong>Materials and methods: </strong>Longitudinal changes in FibroScan-aspartate aminotransferase (FAST) score were measured in 888 patients with type 2 diabetes. Use of pioglitazone, GLP1RA and/or SGLT2i was defined as continuous prescriptions of ≥180 days prior to their last reassessment FibroScan. Multivariable logistic regression analysis was conducted to evaluate the associations between use of these agents and FAST score changes.</p><p><strong>Results: </strong>Over a median follow-up of 3.9 years, the increasing number of these agents used was significantly associated with more reductions in FAST score (p for trend <0.01). Dual combination was independently associated with a higher likelihood of achieving low FAST score at reassessment than single use of any of these agents (odds ratio [OR] 2.84, p = 0.01). Among the different drug combinations, using SGLT2i and pioglitazone (median dose 15 mg daily) together, as compared to not using any of these three agents, was associated with a higher likelihood of both low FAST score at reassessment (OR 6.51, p = 0.008) and FAST score regression (OR 12.52, p = 0.009), after adjusting for changes in glycaemic control and body weight during the study.</p><p><strong>Conclusions: </strong>Combining SGLT2i and pioglitazone is a potentially useful strategy to ameliorate 'at-risk' MASH in patients with type 2 diabetes.</p>","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":" ","pages":"574-582"},"PeriodicalIF":5.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142574946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glycaemic response to pasta from three different wheat varieties in individuals with type 2 diabetes. 2 型糖尿病患者对三种不同小麦品种面食的血糖反应。
IF 5.4 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-02-01 Epub Date: 2024-11-25 DOI: 10.1111/dom.16082
Ilaria Dicembrini, Giuseppe Cavallo, Francesco Ranaldi, Daniele Scoccimarro, Chiara Caiulo, Giovanni A Silverii, Paolo Iovino, Camilla E Magi, Guglielmo Bonaccorsi, Laura Rasero, Edoardo Mannucci
{"title":"Glycaemic response to pasta from three different wheat varieties in individuals with type 2 diabetes.","authors":"Ilaria Dicembrini, Giuseppe Cavallo, Francesco Ranaldi, Daniele Scoccimarro, Chiara Caiulo, Giovanni A Silverii, Paolo Iovino, Camilla E Magi, Guglielmo Bonaccorsi, Laura Rasero, Edoardo Mannucci","doi":"10.1111/dom.16082","DOIUrl":"10.1111/dom.16082","url":null,"abstract":"","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":" ","pages":"1014-1017"},"PeriodicalIF":5.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142714981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Discontinuation of SGLT2i in people with type 2 diabetes following hospitalisation for heart failure: A cause for concern? 2 型糖尿病患者因心力衰竭住院后停用 SGLT2i:值得关注吗?
IF 5.4 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-02-01 Epub Date: 2024-11-07 DOI: 10.1111/dom.16061
Tamara Y Milder, Jialing Lin, Sallie-Anne Pearson, Juliana de Oliveira Costa, Brendon L Neuen, Carol Pollock, Min Jun, Jerry R Greenfield, Richard O Day, Sophie L Stocker, David Brieger, Michael O Falster
{"title":"Discontinuation of SGLT2i in people with type 2 diabetes following hospitalisation for heart failure: A cause for concern?","authors":"Tamara Y Milder, Jialing Lin, Sallie-Anne Pearson, Juliana de Oliveira Costa, Brendon L Neuen, Carol Pollock, Min Jun, Jerry R Greenfield, Richard O Day, Sophie L Stocker, David Brieger, Michael O Falster","doi":"10.1111/dom.16061","DOIUrl":"10.1111/dom.16061","url":null,"abstract":"","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":" ","pages":"997-1000"},"PeriodicalIF":5.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142602518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1